Johnson & Johnson

173.69+0.3300+0.19%Vol 4.28M1Y Perf 16.84%
Aug 5th, 2021 16:00 DELAYED
BID173.00 ASK174.27
Open173.85 Previous Close173.36
Pre-Market- After-Market173.80
 - -  0.11 0.06%
Target Price
187.22 
Analyst Rating
Moderate Buy 1.56
Potential %
7.79 
Finscreener Ranking
★★+     47.34
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★+     48.28
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★+     56.48
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
★★+     44.11
Price Range Ratio 52W %
97.80 
Earnings Rating
Neutral
Market Cap457.39B 
Earnings Date
21st Jul 2021
Alpha-0.00 Standard Deviation0.05
Beta0.72 

Today's Price Range

172.42173.85

52W Range

133.65174.59

5 Year PE Ratio Range

17.20310.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.87%
1 Month
3.41%
3 Months
3.55%
6 Months
5.62%
1 Year
16.84%
3 Years
31.56%
5 Years
40.73%
10 Years
218.89%

TickerPriceChg.Chg.%
JNJ173.690.33000.19
AAPL147.060.11000.07
GOOG2 738.8018.23000.67
MSFT289.523.01001.05
XOM57.200.36000.63
WFC46.990.84001.82
FB362.974.05001.13
GE103.020.11000.11
JPM153.151.91001.26
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.40
0.30
0.48
87.10
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
67.00
22.80
31.20
20.20
19.92
RevenueValueIndustryS&P 500US Markets
89.19B
33.88
1.89
3.71
DividendsValueIndustryS&P 500US Markets
2.46
4.24
5.06
5.57
Payout ratio72.00
Earnings HistoryEstimateReportedSurprise %
Q02 20212.282.488.77
Q01 20212.312.5912.12
Q04 20201.811.862.76
Q03 20201.992.2010.55
Q02 20201.501.6711.33
Q01 20202.032.3013.30
Q04 20191.861.881.08
Q03 20192.002.126.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR2.38-2.06Negative
12/2021 QR2.20-1.35Negative
12/2021 FY9.651.37Positive
12/2022 FY10.300.39Positive
Next Report Date-
Estimated EPS Next Report2.28
Estimates Count7
EPS Growth Next 5 Years %6.50
Volume Overview
Volume4.28M
Shares Outstanding2.63B
Shares Float2.63B
Trades Count56.12K
Dollar Volume2.20B
Avg. Volume7.39M
Avg. Weekly Volume4.58M
Avg. Monthly Volume5.89M
Avg. Quarterly Volume6.35M

Johnson & Johnson (NYSE: JNJ) stock closed at 173.69 per share at the end of the most recent trading day (a 0.19% change compared to the prior day closing price) with a volume of 4.29M shares and market capitalization of 457.39B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 136400 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is 16.84%, while year-to-date (YTD) performance is 10.36%. JNJ stock has a five-year performance of 40.73%. Its 52-week range is between 133.65 and 174.59, which gives JNJ stock a 52-week price range ratio of 97.80%

Johnson & Johnson currently has a PE ratio of 25.90, a price-to-book (PB) ratio of 6.89, a price-to-sale (PS) ratio of 5.08, a price to cashflow ratio of 19.00, a PEG ratio of 2.32, a ROA of 10.61%, a ROC of 18.25% and a ROE of 26.81%. The company’s profit margin is 19.92%, its EBITDA margin is 31.20%, and its revenue ttm is $89.19 Billion , which makes it $33.88 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.28 for the next earnings report. Johnson & Johnson’s next earnings report date is -.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (1.56), with a target price of $187.22, which is +7.79% compared to the current price. The earnings rating for Johnson & Johnson stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.46% with a dividend per share of $4.24 and a payout ratio of 72.00%.

Johnson & Johnson has a Buy technical analysis rating based on Technical Indicators (ADX : 9.67, ATR14 : 1.89, CCI20 : 97.36, Chaikin Money Flow : 0.09, MACD : 1.72, Money Flow Index : 69.13, ROC : 3.11, RSI : 65.73, STOCH (14,3) : 90.29, STOCH RSI : 0.24, UO : 56.90, Williams %R : -9.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $0), Ashley McEvoy (Option Excercise at a value of $0), Jennifer L. Taubert (Option Excercise at a value of $0), Joaquin Duato (Option Excercise at a value of $0), Joseph J. Wolk (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $1 027 323), Kathryn E. Wengel (Sold 16 115 shares of value $2 473 937 ), Michael E. Sneed (Option Excercise at a value of $6 799 952), Michael E. Sneed (Sold 109 324 shares of value $16 718 918 ), Michael H. Ullmann (Option Excercise at a value of $0), Paulus Stoffels (Option Excercise at a value of $0), Peter M. Fasolo (Option Excercise at a value of $0), Robert J. Decker (Option Excercise at a value of $0), Thibaut Mongon (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (68.75 %)
11 (68.75 %)
10 (66.67 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (6.67 %)
Hold
4 (25.00 %)
4 (25.00 %)
4 (26.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Moderate Buy
1.56
Moderate Buy
1.60

Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

CEO: Alex Gorsky

Telephone: +1 732 524-0400

Address: One Johnson and Johnson Plaza, New Brunswick 08933, NJ, US

Number of employees: 136 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

55%45%

Bearish Bullish

52%48%

News

Stocktwits